"Thrombolytic Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
| Descriptor ID |
D015912
|
| MeSH Number(s) |
E02.319.913
|
| Concept/Terms |
Thrombolytic Therapy- Thrombolytic Therapy
- Therapeutic Thrombolysis
- Therapeutic Thrombolyses
- Thrombolyses, Therapeutic
- Thrombolysis, Therapeutic
- Therapy, Fibrinolytic
- Fibrinolytic Therapies
- Therapies, Fibrinolytic
- Therapy, Thrombolytic
- Therapies, Thrombolytic
- Thrombolytic Therapies
- Fibrinolytic Therapy
|
Below are MeSH descriptors whose meaning is more general than "Thrombolytic Therapy".
Below are MeSH descriptors whose meaning is more specific than "Thrombolytic Therapy".
This graph shows the total number of publications written about "Thrombolytic Therapy" by people in this website by year, and whether "Thrombolytic Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 0 | 4 |
| 1996 | 1 | 2 | 3 |
| 1997 | 2 | 4 | 6 |
| 1998 | 3 | 1 | 4 |
| 1999 | 2 | 2 | 4 |
| 2000 | 6 | 5 | 11 |
| 2001 | 8 | 3 | 11 |
| 2002 | 1 | 1 | 2 |
| 2003 | 2 | 1 | 3 |
| 2004 | 5 | 3 | 8 |
| 2005 | 2 | 2 | 4 |
| 2006 | 2 | 0 | 2 |
| 2007 | 5 | 0 | 5 |
| 2008 | 3 | 3 | 6 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 4 | 3 | 7 |
| 2012 | 1 | 0 | 1 |
| 2013 | 8 | 2 | 10 |
| 2014 | 2 | 2 | 4 |
| 2015 | 6 | 4 | 10 |
| 2016 | 4 | 0 | 4 |
| 2017 | 1 | 1 | 2 |
| 2018 | 3 | 2 | 5 |
| 2019 | 8 | 2 | 10 |
| 2020 | 11 | 5 | 16 |
| 2021 | 5 | 2 | 7 |
| 2022 | 1 | 3 | 4 |
| 2023 | 1 | 1 | 2 |
| 2024 | 1 | 2 | 3 |
| 2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thrombolytic Therapy" by people in Profiles.
-
Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis. Blood Adv. 2025 Nov 11; 9(21):5512-5527.
-
Comparison of combined intravenous and intra-arterial thrombolysis with intravenous thrombolysis alone in stroke patients undergoing mechanical thrombectomy: a propensity-matched analysis. J Neurointerv Surg. 2025 Jun 01; 17(e2):e261-e268.
-
Intrapleural tissue plasminogen activator and deoxyribonuclease in complex pleural effusion and empyema, clinical outcomes, and predictors. Ther Adv Respir Dis. 2025 Jan-Dec; 19:17534666251343711.
-
Anti-stroke biologics: from recombinant proteins to stem cells and organoids. Stroke Vasc Neurol. 2024 Nov 05; 9(5):467-480.
-
A Comparison of Postprocedural Hemoglobin in Catheter-Directed Thrombolysis versus Large-Bore Aspiration Thrombectomy for Acute Pulmonary Embolism. J Vasc Interv Radiol. 2025 01; 36(1):116-123.e1.
-
Management of neonatal and infant aortic thrombosis: A single-center case series. Pediatr Blood Cancer. 2024 Nov; 71(11):e31283.
-
Early REperfusion therapy with intravenous alteplase for recovery of VISION in acute central retinal artery occlusion (REVISION): Study protocol of a phase III trial. Int J Stroke. 2024 Aug; 19(7):823-829.
-
Histotripsy and Catheter-Directed Lytic: Efficacy in Highly Retracted Porcine Clots In Vitro. Ultrasound Med Biol. 2024 08; 50(8):1167-1177.
-
Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. Ann Neurol. 2024 Feb; 95(2):347-361.
-
Treatment of high- and intermediate-high-risk pulmonary embolism by the Pulmonary Embolism Response Team: Focus on catheter-directed therapies. Cardiol J. 2024; 31(2):215-225.